Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis

INTRODUCTION: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). Tofacitinib monotherapy was previously shown to inhibit structural damage, reduce clinical signs and symptoms of RA, and improve physical functioning over 24 months in methotrexate (MTX)-naive...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleischmann, Roy M, Huizinga, Tom W J, Kavanaugh, Arthur F, Wilkinson, Bethanie, Kwok, Kenneth, DeMasi, Ryan, van Vollenhoven, Ronald F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964179/
https://www.ncbi.nlm.nih.gov/pubmed/27493790
http://dx.doi.org/10.1136/rmdopen-2016-000262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964179/
https://www.ncbi.nlm.nih.gov/pubmed/27493790
http://dx.doi.org/10.1136/rmdopen-2016-000262

Ejemplares similares